Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laquinimod DDI with Oral Contraceptives
NCT02085863Phase 1Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Feb 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in multiple sclerosis (MS) comparing Laquinimod Sequence with Placebo Sequence (2 arms). Primary endpoints: Area Under the Curve from 0 to 24 hours and Maximum Plasma Concentration. Started Feb 2014; status: completed.
02
Drugs
laquinimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02085863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02085863.